Treatment of thrombocytopenia in patients with persistent or chronic immune thrombocytopenia.
Treatment of thrombocytopenia in patients with hepatitis C infection.
Treatment of severe aplastic anemia.
Limitations of use: ETP tablet is not indicated for the treatment of patients with myelodysplastic syndromes (MDS). Safety and efficacy have not been established in combination with direct-acting antiviral agents used without interferon for the treatment of chronic hepatitis C infection.